– Glycan–Ligand Screening and Discovery
– Glycan Analysis
– Carbohydrate Synthesis
– Drug Discovery & High-Throughput Screening (HTS)
– Molecular Glycobiology & Glycoengineering
Our services, instruments, technologies and professional services are available to all researchers, from Canada and abroad, across academic, private, and government sectors. The facility’s scientific and technical personnel provides high-quality, high-throughput, and competitively priced products and services to all of its clients.
GlycoNet Integrated Services are funded by the Government of Canada through the Canada Foundation for Innovation – Major Science Initiatives Fund.
GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training of a new generation of glyco-scientists and entrepreneurs. The network includes over 170 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.
GlycoNet is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.
In 2020, 5 of the top 10 selling drugs are glycosylated and have a combined revenue of US$58B.
Global market for glycomics drugs to reach US$257B by 2028.
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.